Company No: 10522796 (England and Wales)

Contents

• Company Information
• Balance Sheet
• Notes to the Financial Statements

Directors	Mary Assimakopoulos
	Mark Angus Jeffery

Registered office	2nd Floor 168 Shoreditch High Street
	London
	E1 6RA
	United Kingdom

Company number

10522796 (England and Wales)

Accountant	Kreston Reeves LLP
	2nd Floor
	168 Shoreditch High Street
	London
	E1 6RA

	Note	2025		2024
		£		£
Fixed assets
Investments	3	11,912,899		11,161,182
		11,912,899		11,161,182
Current assets
Debtors	4	1,745,997		1,713,009
Cash at bank and in hand		211,639		98,588
		1,957,636		1,811,597
Creditors: amounts falling due within one year	5	( 11,761,507)		( 11,760,867)
Net current liabilities		(9,803,871)		(9,949,270)
Total assets less current liabilities		2,109,028		1,211,912
Net assets		2,109,028		1,211,912
Capital and reserves
Called-up share capital	6	2		2
Profit and loss account		2,109,026		1,211,910
Total shareholders' funds		2,109,028		1,211,912

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of MAMJ Holdings Limited (registered number: 10522796) were approved and authorised for issue by the Board of Directors on 17 May 2026. They were signed on its behalf by:

Mark Angus Jeffery Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

MAMJ Holdings Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 2nd Floor 168 Shoreditch High Street, London, E1 6RA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Nonmonetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.


Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of income and retained earnings within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Finance costs

Finance costs are charged to the Profit and Loss Account over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Impairment of assets

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

2. Employees

	2025		2024
	Number		Number
Employees other than the directors, who did not receive any remuneration	0		0

3. Fixed asset investments

	Listed investments		Other investments		Total
	£		£		£
Cost or valuation before impairment
At 01 January 2025	11,164,425		( 3,243)		11,161,182
Movement in fair value	747,492		0		747,492
Net cash invested/(withdrawn)	0		4,225		4,225
At 31 December 2025	11,911,917		982		11,912,899
Carrying value at 31 December 2025	11,911,917		982		11,912,899
Carrying value at 31 December 2024	11,164,425		( 3,243)		11,161,182

4. Debtors

	2025		2024
	£		£
Other debtors	1,745,997		1,713,009

5. Creditors: amounts falling due within one year

	2025		2024
	£		£
Trade creditors	540		0
Amounts owed to directors	11,755,217		11,755,217
Accruals	5,750		5,650
	11,761,507		11,760,867

6. Called-up share capital

	2025		2024
	£		£
Allotted, called-up and fully-paid
2 Ordinary shares of £ 1.00 each	2		2

7. Related party transactions

During the year, the company paid expenses totalling £32,988 (2024: £18,575) on behalf of Research Partnership Investments France. At the year end, the company was owed £1,745,995 (2024: £1,713,007) by Research Partnership Investments France.

At the balance sheet date, a balance of £5,877,609 was owed to Mark Jeffery, a director of the company.

At the balance sheet date, a balance of £5,877,608 was owed to Mary Assimakopoulos , a director of the company.

8. Ultimate controlling party

The Company considers its ultimate control relationship to be M Assimakopoulos and M A Jeffery, as directors and ultimate shareholders. Each director holds 50% of the shareholding in the company.